The staging method developed by Braak and Braak suggests that the neurofibrillary pathology of AD progresses in a relatively predictable sequence across the medial temporal lobe structures, subcortical nuclei, and neocortical areas of the brain in seven stages, with the final stage representing the presence of cortical neurofibrillary changes.

Read more about how Braak’s neurofibrillary pathology correlates with cognitive impairment

file_download Download in HQ

Related content

Next steps for improving clinical trial outcomes in neurodegenerative disease description Article
Next steps for improving clinical trial outcomes in neurodegenerative disease

This article discusses potential next steps for enhancing clinical trial outcomes in neurodegenerative diseases, with the ultimate goal of improving patient care

29.04.2025 Alzheimer’s Disease
The Complexities and Prospects of Dementia Care in the Future play_circle Video play_circle
The Complexities and Prospects of Dementia Care in the Future

Professor Dr. Matthew Kiernan discusses the limitations of current trial models.

04.12.2024 Alzheimer’s Disease
The Challenges and Potential of Clinical Trials in Dementia Research play_circle Video play_circle
The Challenges and Potential of Clinical Trials in Dementia Research

Professor Dr. Matthew Kiernan discusses the limitations of current trial models.

12.11.2024 Alzheimer’s Disease